How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,469 results for

Postpartum Office Visit

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Treatment of Patients with Schizophrenia

, the presenting concerns, the observations of the clinician during the assessment, the complexity and urgency of clinical decision-making, and other aspects of the clinical context. In many circumstances, aspects of the evaluation will extend across multiple visits (American Psychiatric Association 2016a). 19 Table 1. Recommended aspects of the initial psychiatric evaluation adapted from APA's Practice Guidelines for the Psychiatric Evaluation of Adults, 3rd edition History of Present Illness • Reason (...) that the patient is presenting for evaluation, including current symptoms, behaviors, and precipitating factors • Current psychiatric diagnoses and psychiatric review of systems Psychiatric History • Hospitalization and emergency department visits for psychiatric issues, including substance use disorders • Psychiatric treatments (type, duration, and, where applicable, doses) • Response and adherence to psychiatric treatments, including psychosocial treatments, pharmacotherapy, and other interventions

2020 American Psychiatric Association

82. Prenatal Care

postpartum follow up is a contact at 10-14 days after delivery and an office visit 4 weeks’ postpartum. Timing of the office visit has traditionally been between 6-8 weeks, but patients may benefit from earlier surveillance for postpartum depression, breastfeeding issues and/or contraception initiation. The following should be included in the postpartum visit: • Pelvic and breast examinations as needed • Cervical cytology should be completed at six to eight weeks’ postpartum if indicated by cervical (...) term risk for cancer and cirrhosis. -Screen all patients for depression during the third trimester. -Provide contraceptive counseling during the third trimester teaching. -Review future chronic disease risks with patients during pregnancy and at the postpartum visit. Progesterone therapy. Progesterone should be offered to patients who have a history of prior spontaneous preterm birth or who are found to have a shortened cervix on ultrasound [I-A]. STI testing. Test all women for sexually

2020 University of Michigan Health System

83. Public health guidance on prevention and control of blood-borne viruses in prison settings

(Spain); Stefan Enggist, Hans Wolff (Switzerland); Sharon Hutchinson (UK); Alison Hannah (Penal Reform International); Jan Malinowski (Council of Europe); Lars Møller (World Health Organization, Office for Europe); and Ehab Salah (United Nations on Drugs and Crime). The authors would like to acknowledge the contributions to the project from Andrew J Amato-Gauci, Tarik Derrough, Erika Duffell, Teymur Noori, Anastasia Pharris, Ettore Severi (ECDC) and Linda Montanari and Marica Ferri (EMCDDA (...) treatment in prison settings 27 Table 11. Evidence for the effectiveness of interventions to prevent BBVs post-release 29 Table 12. Evidence for the effectiveness of interventions to increase linkage to care post-release 30 Public health guidance on prevention and control of blood-borne viruses in prison settings SCIENTIFIC ADVICE iv Abbreviations AIDS Acquired immune deficiency syndrome ALT Alanine aminotransferase ART Antiretroviral therapy BBV Blood-borne virus CD4 Cluster of differentiation 4 DAAs

2019 European Centre for Disease Prevention and Control - Public Health Guidance

84. Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA

(International Organisation for Migration), Denis Onyango (Africa Advocacy Foundation), Kathy Attawell and Andreas Sandgren (independent consultants), Alexandra Ortega (International Panel Physicians Association), and Joao Pires and Santino Severoni (World Health Organization, Regional Office for Europe). ECDC would also like to acknowledge the Cochrane and Campbell Equity Methods Group and the following researchers for supporting the systematic evidence reviews, GRADE evidence profiles and GRADE evidence (...) screening and vaccination, in terms of delays to presentation, follow-up appointments, and uptake and completion of treatment, and take steps to reduce post-screening/testing drop-out from care. • Recognise that newly arrived migrants face a range of issues (for example, housing, employment, mental health problems) that may take precedence over seeking preventative healthcare and that may increase the risks or consequences of infectious diseases. The ad hoc scientific panel members strongly supported

2019 European Centre for Disease Prevention and Control - Public Health Guidance

85. Implementing Telehealth in Practice

“telehealth” refers to the technology-enhanced health care framework that includes services such as virtual visits, remote patient monitoring, and mobile health care. Evidence suggests that telehealth provides comparable health outcomes when compared with traditional methods of health care delivery without compromising the patient–physician relationship, and it also has been shown to enhance patient satis- faction andimprovepatientengagement.Obstetrician (...) and monitoring that are delivered by technol- ogy. “Connected health” and “digital health” also are terms that broadly describe similar technology applica- tions in health care. The term “telehealth” is now more commonly used to describe a wide range of topics, such as diagnosis and management, education, and other related fields of health care. For this document, the term “telehealth” refers to the technology-enhanced health care framework that includes services such as virtual visits, remote patient

2020 American College of Obstetricians and Gynecologists

86. Management of Type 2 Diabetes Mellitus

the long-term benefits of earlier diagnosis in this population are uncertain, both expert opinion and the epidemiology of diabetes post- GDM support screening. The optimal test for screening in this group is not clear. The ADA currently recommends screening with a 2 hour, 75 gram oral glucose tolerance test (OGTT) at 6-12 weeks postpartum. The frequency and method of screening after this point is debated. Our current recommendation for these patients is that A1c be used as the screening test of choice (...) of risk factors and complications is summarized in Table 12. Diet, exercise, and pharmacologic interventions should be initiated for: Hypertension [IA] Cardiovascular risk reduction [IA] Hyperlipidemia [IA] Diabetes complications as indicated Each regular diabetes visit Annually • Blood pressure measured and controlled [IA]. • Check HbA1c every 3 months if on insulin; every 6 months if on oral agents or diet only and well- controlled. [II]. Optimize glycemic control [IA]. • Review and reinforce diet

2020 University of Michigan Health System

87. Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases

under Contract No. 290-2015-00006-I/290-320011-T.) AHRQ Publication No. 20-EHC004-EF. Rockville, MD: Agency for Healthcare Research and Quality. March 2020. Posted final reports are located on the Effective Health Care Program search page. DOI: https://doi.org/10.23970/AHRQEPCTB34. iv Preface The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private (...) on the appropriate conceptual framework and critical issues that will inform future research. AHRQ expects that the EPC evidence reports and technology assessments will inform individual health plans, providers, and purchasers as well as the healthcare system as a whole by providing important information to help improve healthcare quality. If you have comments on this Technical Brief, they may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fishers Lane

2020 Effective Health Care Program (AHRQ)

88. Treatment of Depression in Children and Adolescents

and Quality; April 2020. DOI: https://doi.org/10.23970/AHRQEPCCER224. Posted final reports are located on the Effective Health Care Program search page. iv Preface The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based Practice Centers (EPCs), sponsors the development of systematic reviews to assist public- and private-sector organizations in their efforts to improve the quality of healthcare in the United States. These reviews provide comprehensive, science-based information (...) studies. For more information about AHRQ EPC systematic reviews, see www.effectivehealthcare.ahrq.gov/reference/purpose.cfm. AHRQ expects that these systematic reviews will be helpful to health plans, providers, purchasers, government programs, and the healthcare system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the website (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an email list

2020 Effective Health Care Program (AHRQ)

89. COVID-19: Operational framework for maternity and neonatal services

Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en For further information, contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, For permissions beyond the scope of this licence, contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer (...) on provision of high risk services Birthing services • Continue services • Maximise access for privately practising midwives (credentialled) and general practitioner-obstetricians Postnatal services • Continue inpatient services as clinically necessary • Redirect postnatal care to community based midwifery care where possible (e.g. home visits) Obstetric theatres • Consider use relative to demand • Maintain emergency obstetrics capacity • Consider impact of theatre infection control procedures on theatre

2020 Queensland Health

90. WHO recommendation on Calcium supplementation before pregnancy for the prevention of pre-eclampsia and its complications

(International Confederation of Midwives), Gerard Visser (International Federation of Gynaecology and Obstetrics) and Charlotte Warren (Ending Eclampsia Project, Population Council). We also appreciate the contributions of WHO Regional Offices’ staff – Nino Berdzuli, Bremen De Mucio, Chandani Anoma Jayathilaka, Ramez Khairi Mahaini, Léopold Ouedraogo, Howard Sobel and Claudio Sosa. WHO acknowledges the financial support for this work received from the United States Agency for International Development (...) of their enjoyment of sexual and reproductive health and rights, and living a life of dignity (4). The World Health Organization (WHO) envisions a world where “every pregnant woman and newborn receives quality care throughout the pregnancy, childbirth and the postnatal period” (5). There is evidence that effective interventions exist at reasonable cost for the prevention or treatment of virtually all life-threatening maternal complications (6). Almost two thirds of the global maternal and neonatal disease burden

2020 World Health Organisation Guidelines

91. Opioid Treatments for Chronic Pain

already prescribed opioids were not addressed in this review. Evidence on the effectiveness of risk mitigation strategies also remains very limited. One new observational study found provision of naloxone to patients prescribed opioids in primary care clinics associated with decreased likelihood of emergency department visits, but no difference in risk of overdose. 41 Evidence of opioid tapering versus usual care was largely limited to a trial that found a taper support intervention associated (...) are at high risk for opioid-related adverse events. No trial compared different rates of opioid tapering, though one observational study found an association between longer time to opioid discontinuation in patients on long-term, high-dose opioid therapy and decreased risk of opioid-related emergency department visit or hospitalization. 45 The Food and Drug Administration recently issued a warning on not discontinuing long-term opioid therapy abruptly. 46 No study evaluated the effectiveness of risk

2020 Effective Health Care Program (AHRQ)

92. Breastfeeding Guidance Post Hospital Discharge for Mothers or Infants with Suspected or Confirmed SARS-Co V-2 Infection

calorie content of her milk. The expressed milk can be fed to the infant by a healthy caregiver. Support should be provided to the mother to reintroduce direct breastfeeding when she is well. Mother’s milk supply is established in the first few weeks postpartum, so this is a critical time to support milk production. Families should be reassured that mothers’ milk is safe and important for baby. Mother chose not to breastfeed during the first weeks after birth During the first week post-partum (...) . Implement strategies such as seeing newborns first thing in the morning, using separate entrances for well/sick, rooming upon arrival, or waiting in car until appointment time. The gold standard for optimal breastfeeding support is an office visit within 1-2 days of discharge, with infant exam, weight check, and direct observation of latch and feeding. For pediatric practices that continue to provide visits in the newborns’ medical home, offering breastfeeding support as part of these visits is crucial

2020 American Academy of Pediatrics

93. Management of Infants Born to Mothers with Suspected or Confirmed COVID-19

-19 infection provides no advantage to the newborn or family . Early discharge may place additional burdens on families to access , and on outpatient pediatric offices to provide recommended newborn care , screenings, and outpatient follow-up . In-person post-discharge visits are the preferred means to provide timely newborn screening, bilirubin testing, feeding and weight assessments. Additional Information: Interim Guidance Disclaimer: The COVID-19 clinical interim guidance provided here has (...) unaffected infants. Gowns, gloves, standard procedural masks, and eye protection (faceshields or goggles) should be used while caring for these newborns. However, separation of mother and infant has downsides . If after discussion with the clinical care team , the mother chooses to room-in , or if rooming-in is necessary because the healthcare facility cannot provide care for the infant in a separate area, specific steps should be taken to minimize the risk of the newborn acquiring postnatal SARS-CoV-2

2020 American Academy of Pediatrics

94. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

; therefore, early ambulatory visits in the first 1 to 2 weeks after delivery or home blood pressure monitoring may be prudent. Medication in the first few weeks postpartum should be adjusted to maintain a systolic blood pressure not higher than 150 mm Hg and a diastolic blood pressure not higher than 100 mm Hg. For those women with persistent hypertension beyond 6 weeks to 3 months postpartum, blood pressure management should be initiated as per the current American College of Cardiology/AHA guidelines (...) of pregnancy-related mortality in the United States. Advancing maternal age and preexisting comorbid conditions have contributed to the increased rates of maternal mortality. Preconception counseling by the multidisciplinary cardio-obstetrics team is essential for women with preexistent cardiac conditions or history of preeclampsia. Early involvement of the cardio-obstetrics team is critical to prevent maternal morbidity and mortality during the length of the pregnancy and 1 year postpartum. A general

2020 American Heart Association

95. Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease

reproductive-aged women with acute EVD, does being pregnant alter the outcome of the acute EVD? 2. Among pregnant women, how does acute EVD alter maternal, pregnancy, and neonatal outcomes? 3. Among EVD survivors, does being pregnant, postpartum or post-abortion alter EBOV persistence in body fluids such as breastmilk and other pregnancy-related body fluids and tissues? 4. Among women infected with EBOV, does a history of EVD alter subsequent preg- nancy outcomes?Guidelines for the management of pregnant (...) and breastfeeding women in the context of Ebola virus disease 2 Acronyms and abbreviations AFRO Regional Office for Africa (at WHO) CDC Centers for Disease Control and Prevention (the United States of America) CT cycle threshold DSMB Data and Safety Monitoring Board EBOV Ebola virus ETC Ebola treatment centre EtD evidence-to-decision EVD Ebola virus disease (acute EVD refers to laboratory-confirmed (positive viremia) and symptomatic Ebola virus disease) GCP good clinical practice GDG Guideline Development Group

2020 World Health Organisation Guidelines

96. Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association

a healthcare facility also can impede access to care. People who lack reliable transportation are often not able to keep clinic appointments. A linchpin of post-hospital follow-up for HF is a clinic follow-up visit within 7 days of hospital discharge, which has been shown in many studies to reduce readmission rates. Missing the postdischarge follow-up appointment or any other clinic appointments because of distance from a health facility or lack of transportation is likely to interfere with efforts (...) and Brooks-Gunn conducted the Moving to Opportunity study, which is the only randomized study that assigned participants to high- versus low-income neighborhoods according to a voucher system. After 3 years, 550 families were reinterviewed. Those in higher-income neighborhoods reported significantly lower stress and anxiety, lower obesity, and fewer health-related comorbidities. Consistent with these findings, other observational studies have demonstrated fewer inpatient and outpatient visits and fewer

2020 American Heart Association

97. Management of Stillbirth

to evaluate and classify stillbirths and by decreasing autopsy rates. In most cases, stillbirth certificates are filled out before a full postnatal investigation has been completed and amended death certificates are rarely filed when additional information from the stillbirth evaluation emerges. In any specific case, it may be difficult to assign a definite cause to a stillbirth. A significant proportion of stillbirths remains unexplained even after a thorough evaluation . Fetal Growth Restriction Fetal (...) management recommendations for women with a previous stillbirth are listed in . Box 1. Management of Subsequent Pregnancy After Stillbirth Prepregnancy or Initial Prenatal Visit Detailed medical and obstetric history Evaluation and workup of previous stillbirth Determination of recurrence risk Smoking cessation Weight loss in obese women (prepregnancy only) Genetic counseling if family genetic condition exists Diabetes screen Acquired thrombophilia testing: lupus anticoagulant as well as IgG and IgM

2020 American College of Obstetricians and Gynecologists

98. Tobacco and Nicotine Cessation During Pregnancy

cessation-aid services and resources, including digital resources , should be discussed and documented regularly at prenatal and postpartum follow-up visits . There currently is insufficient evidence to determine the effect of mindfulness , hypnosis , or acupuncture for smoking cessation . Box 1. Five A’s of Tobacco and Nicotine Cessation 1. ASK the patient about all types of tobacco or nicotine use* at the first prenatal visit and follow up with her at subsequent visits. The patient should choose (...) . Although cumulative data are limited, maternal bupropion doses of up to 300 mg are associated with low levels of detection in breastmilk that are unlikely to cause adverse effects in infants . Because no published information is available regarding the use of varenicline during lactation, an alternative drug is preferable, especially with newborn or preterm infants . Coding Office visits that specifically address smoking cessation should be coded as such, but benefits are subject to specific plan

2020 American College of Obstetricians and Gynecologists

99. Early onset Group B streptococcal disease

Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, phone (07) 3131 6777. For permissions beyond the scope of this licence contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Early onset Group B Streptococcal disease Refer to online version, destroy printed copies after use Page 3 of 26 Flow Chart: Maternal management of early onset (...) is licensed under a Creative Commons Attribution Non-Commercial No Derivatives 3.0 Australia licence. In essence, you are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc- nd/3.0/au/deed.en For further information contact Queensland

2020 Queensland Health

100. Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium

For further information contact Queensland Clinical Guidelines RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, phone (07) 3131 6777. For permissions beyond the scope of this licence contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: VTE prophylaxis in pregnancy and the puerperium Refer to online version, destroy printed copies after use Page 3 of 25 Flow (...) for thromboprophylaxis 13 Table 8. Other pharmaceutical agents 14 Table 9. Antenatal prophylaxis 15 Table 10. Prophylaxis postpartum by assessment of risk 16 Table 11. Management of LMWH, UFH and neuraxial blockade 17 Table 12. Antenatal and postnatal management of specific patient groups 18 Table 13. Preparation for discharge 19 Queensland Clinical Guideline: VTE prophylaxis in pregnancy and the puerperium Refer to online version, destroy printed copies after use Page 7 of 25 1 Introduction Pulmonary embolism (PE

2020 Queensland Health

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>